Schedule 13G ownership disclosure

LifeStance Health Group Inc

Common Stock, par value $0.01 per share · CUSIP: 53228F101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Summit Partners, L.P.

    Shares: 33,524,715 · Class: 8.62%

  • Summit Partners Growth Equity Fund IX-A, L.P.

    Shares: 20,529,149 · Class: 5.28%

  • Summit Partners Growth Equity Fund IX-B, L.P.

    Shares: 12,818,117 · Class: 3.30%

  • Summit Investors GE IX/VC IV (UK), L.P.

    Shares: 14,991 · Class: 0.01%

  • Summit Partners Entrepreneur Advisors Fund II, L.P.

    Shares: 19,157 · Class: 0.01%

  • Summit Investors GE IX/VC IV, LLC

    Shares: 143,301 · Class: 0.04%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-280127
Form type
SCHEDULE 13G/A
Filer
LifeStance Health Group, Inc.
CIK
CIK 1845257
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub